These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9180125

  • 1. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart.
    Morris SD, Yellon DM.
    J Am Coll Cardiol; 1997 Jun; 29(7):1599-606. PubMed ID: 9180125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Anning PB, Grocott-Mason RM, Lewis MJ.
    Endothelium; 1997 Jun; 5(4):265-75. PubMed ID: 9588818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms.
    Sato M, Engelman RM, Otani H, Maulik N, Rousou JA, Flack JE, Deaton DW, Das DK.
    Circulation; 2000 Nov 07; 102(19 Suppl 3):III346-51. PubMed ID: 11082412
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium.
    Rump LC, Berlit T, Schwertfeger E, Beyersdorf F, Schollmeyer P, Bohmann C.
    J Hypertens; 1997 Nov 07; 15(11):1263-70. PubMed ID: 9383175
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2-receptor gene.
    Emanueli C, Angioni GR, Anania V, Spissu A, Madeddu P.
    J Hypertens; 1997 Dec 07; 15(12 Pt 2):1701-6. PubMed ID: 9488225
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Delayed preconditioning via Angiotensin-converting enzyme inhibition: pros and cons from an experimental study.
    Marktanner R, Nacke P, Feindt P, Hohlfeld T, Schipke JD, Gams E.
    Clin Exp Pharmacol Physiol; 2006 Sep 07; 33(9):787-92. PubMed ID: 16922807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats.
    Takada J, Ibayashi S, Nagao T, Ooboshi H, Kitazono T, Fujishima M.
    Stroke; 2001 May 07; 32(5):1216-9. PubMed ID: 11340236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.
    Auch-Schwelk W, Bossaller C, Claus M, Graf K, Gräfe M, Fleck E.
    Cardiovasc Res; 1993 Feb 07; 27(2):312-7. PubMed ID: 8386065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.